The Department of the Navy Bureau of Medicine and Surgery awarded a $54,663 delivery order contract to Microgenics Corporation Clinical Diagnostics Division for benzodiazepine reagent kits. As the prime contractor, Microgenics will provide the requested reagent kits to support substance screening programs within the Navy medicine community. The contract has a period of performance from August 7, 2023 through December 13, 2023 and utilizes a firm fixed price structure. Thermo Electron Corporation...
The Department of the Navy Bureau of Medicine and Surgery awarded a $104,446.98 firm fixed price delivery order contract to Microgenics Corporation Clinical Diagnostics Division for benzodiazepine reagent kits. As the prime contractor, Microgenics will provide the requested reagent kits to support the Department of the Navy's medical programs. The contract has a period of performance from August 15-24, 2023. Thermo Electron Corporation Financial Services Division is identified as the parent...
The Department of the Navy Bureau of Medicine and Surgery awarded a $100,594.00 firm fixed price delivery order to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, for the provision of benzodiazepine reagent kits. This order was not set aside for any specific business type. The order was placed under a larger indefinite delivery contract the Navy Bureau of Medicine and Surgery has with Microgenics for benzodiazepine reagents, valued at up to $5.5...
Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a firm fixed price delivery order from the Defense Health Agency valued at $50,759.28. The order is for CEDIA benzodiazepine test kits to support substance abuse testing and treatment programs across military medical facilities. Performance will occur at Microgenics' locations in Fremont, California and Waukegan, Illinois, leveraging the financial resources of parent company Thermo Electron...
This is a Firm Fixed Price delivery order awarded by the Defense Health Agency to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of Benzodiazepine Reagent Kits to support the Forensic Toxicology Drug Testing Laboratory (FTDTL) at Tripler Army Medical Center in Hawaii. The award has a total potential value of $101,518.56 and a completion date of March 19, 2024. Microgenics is a manufacturer of clinical diagnostic products and toxicology testing solutions, and...
The Department of the Air Force Air Education and Training Command awarded a $271,414.00 firm fixed price delivery order contract to Microgenics Corporation, a clinical diagnostics division of parent company Thermo Electron Corporation Financial Services Division. The contract is for the provision of benzodiazepine reagent laboratory products and services, with delivery to occur by October 12, 2022. Microgenics has received multiple similar awards from military medical agencies totaling over...
Microgenics Corporation Clinical Diagnostics Division, a subsidiary of Thermo Electron Corporation Financial Services Division, has been awarded a $24,078 firm fixed price delivery order by the Department of the Navy Bureau of Medicine and Surgery to provide 500 DRI-ECSTASY PLUS MDMA/MDA reagent kits. The order is to be performed over a period of nine days in Fremont, California and will support the Department of the Navy's drug testing programs. No subcontractors or set aside designations...
This is a federal contract award issued by the Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation, a clinical diagnostics manufacturer. The $50,759.28 firm fixed price delivery order is for the supply of benzodiazepine reagent kits. The contract has no set-aside designation. Microgenics Corporation is the prime contractor and this award is part of a larger indefinite delivery contract valued at $5,515,434.90 for benzodiazepine reagent kits. The contracts support the...
The Defense Health Agency awarded a $20,065 firm fixed price delivery order contract to Microgenics Corporation for DRI ECSTASY PLUS 500 ML MDMA/MDA reagent kits. As a division of Thermo Electron Corporation, Microgenics will deliver the requested reagent to the Tripler Army Medical Center in Hawaii to support drug testing and analysis. No set aside provisions were included in this award issued under an unspecified government-wide acquisition contract vehicle. The place of performance is...
The Department of the Navy Bureau of Medicine and Surgery awarded a $4,013 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. Microgenics Corporation, a division of Thermo Electron Corporation, will deliver the requested MDMA/MDA testing reagents to the Navy's medical facility in Fremont, California by the completion date of June 17, 2022. The reagents will support the Bureau of Medicine and Surgery's clinical diagnostic operations through...